We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Additional Aggressive Cancers Can Be Found Using Breast MRI Following Mammography Screening

By MedImaging International staff writers
Posted on 25 Nov 2015
The results of a study published online in the journal Radiology have shown that performing MRI scans, after the discovery of mammography breast cancer findings, sometimes shows larger and more aggressive tumors than those discovered in mammography.

Breast Magnetic Resonance Imaging (MRI) is widely used for the screening of high-risk patients, and pre-surgical planning, and is the most sensitive imaging technique available for detecting breast cancer. In younger women, and those with dense breasts, MRI can detect cancers that have two or more distinct primary tumors, often in different breast quadrants. Most of the so-called multicentric cancers were discovered in women with heterogeneously dense or very dense breasts, but cancer was also found in 19% of patients with fatty or scattered fibro-glandular tissue.

The researchers reviewed the records of 2,021 patients that had newly-diagnosed breast cancer, had preoperative MRI, and a biopsy. The MRI detected additional cancers that were not found in the mammography, in 14% (285) of the patients. In 25.6% (73) of the 285 patients the MRI revealed one or more additional cancers in a different breast quadrant than the index cancer, or that detected by breast palpation and/or mammography. In 17 of the 73 patients (23.3%) the multicentric cancers were larger than the known index cancer. The MRI scan also detected multicentric cancers larger than 1 cm in 25% of the 73 patients.

Lead author of the study, Chiara Iacconi, MD, Breast Unit, USL1 Massa-Carrara, (Carrara, Italy), said, “Patients with clinically insignificant cancers undergoing potential overtreatment versus patients who may be undertreated is at the heart of the controversy surrounding breast MRI. We believe invasive cancer larger than 1 centimeter is clinically relevant disease. In general, it is accepted that radiation can likely treat invasive cancer less than 1 centimeter, but lesions larger than 1 centimeter, especially invasive carcinomas, may not be reliably treated with conservation. The results show that multicentric cancer detected on breast MRI after mammography appears to represent a larger tumor burden in approximately a quarter of patients and can result in potential changes to cancer grade and treatment.

Related Links:

USL1 Massa-Carrara



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
DR Flat Panel Detector
1500L
Color Doppler Ultrasound System
DRE Crystal 4PX
Ultrasound System
Acclarix AX9

Latest MRI News

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients